StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
300889.SZ$22.77+0.66%
Fair $22.77+0.0%

300889.SZ

300889.SZ

Technology / Electronic ComponentsShenzhen

$22.77

+0.15 (+0.66%)

Fairly Valued+0.0%Fair Value $22.77Fund rank 24/100 · Data gapFallback financials|
SA 29/D
F-Score: 5/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 18%

FCF escenarios

weak_data · normalized FCF $10.7M · quality 43.7/100

Data gap 24/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 5/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

29/100

D

Piotroski

5/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is -5.5%, below the 5% threshold
Thesis & Journal · 300889.SZLocal privado en este navegador · 300889.SZ
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$0

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

-5.5%

↓

Gross Margin

18.5%

↓

Debt/Equity

0.29

↑
52-Week Range$23
$12$31

TradingView lightweight chart

300889.SZ price, volumen y niveles de valoración

Último $23.05Periodo -49.7%
Fair value: $22.77

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+9.2%

FCF CAGR

—

FCF margin

0.9%

FCF / Net income

-0.14x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $1.18B · net income $-77.2M · FCF $10.7M

2022-FY → 2025-FY

Gross margin

18.5%-12.3% pts

Operating margin

-2.2%-8.9% pts

Net margin

-6.6%-10.5% pts

FCF margin

0.9%+56.1% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$1.18B$1.18B$903.2M$1.07B$905.3M
Net Income$-77.2M$-77.2M$-107.4M$34.3M$36.1M
EBITDA$-2.6M$-2.6M$-63.9M$101.0M$91.5M
EPS-0.36-0.36-0.490.160.17
Gross Margin18.5%18.5%19.5%29.7%30.9%
Operating Margin-2.2%-2.2%-10.7%6.2%6.7%
Net Margin-6.6%-6.6%-11.9%3.2%4.0%
Balance Sheet
Debt/Equity0.290.290.210.210.12
Current Ratio1.321.32———
Cash Flow
Free Cash Flow$10.7M$10.7M$68.4M$-164.6M$-499.4M
Returns
ROE-5.5%-5.5%-7.2%2.1%2.3%
Valuation
P/E———74.5458.11
EV/EBITDA———23.4918.62
P/B3.553.551.281.591.32
Growth & Yield
Revenue Growth30.5%30.5%-15.4%17.9%—
EPS Growth28.0%28.0%-413.7%-4.5%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +85.6%

Total return

+85.6%

Start / end P/E

n/dx → n/dx

EPS bridge

-0.49 → -0.36

Residual

+85.6%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term+85.6%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.